Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 545

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Antibiotic Resistance in India: Drivers and Opportunities for Action

Open access
Laxminarayan, Ramanan, Chaudhury, Ranjit Roy · 2016 · PLOS Medicine

Abstract

Antibiotic Resistance and Use in IndiaAntibiotic resistance is a global public health threat [1], but nowhere is it as stark as in India [2].The crude infectious disease mortality rate in India today is 416.75 per 100,000 persons (author calculations based on World Bank data and the Global Burden of Disease, 1990 [1,2]) and is twice the rate prevailing in the United States when antibiotics were introduced (roughly 200 per 100,000 persons) [3].A mix of poor public health systems and hospital infection, high rates of infectious disease, inexpensive antibiotics, and rising incomes is coming together to increase prevalence of resistant pathogens and is increasing the burden of untreatable neonatal sepsis and health-care-associated infections [4]. Summary Points• Antibiotic use is a major driver of resistance.In 2010, India was the world's largest consumer of antibiotics for human health.• Access to antibiotics is rising, which portends well for the large proportion of India's population that has thus far had poor access to these life-saving drugs.• The convergence of factors such as poor public health infrastructure, rising incomes, a high burden of disease, and cheap, unregulated sales of antibiotics has created ideal conditions for a rapid rise in resistant infections in India.• Over-the-counter, nonprescription sales of carbapenems in India are among the highest in the world and contribute to growing carbapenem resistance among Gram-negative organisms.• Improving regulation of drug production and sales, better managing physician compensation, and encouraging behavior change among doctors and patients are of immediate priority.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1001974

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 545

Metadata

Authors
Laxminarayan, R., & Chaudhury, R. R.
Venue
PLOS Medicine
Published
2016-03-02
Volume
13
Issue
3
Pages
e1001974
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2290464731
Cited by
545
References
20
FWCI
36.28
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibiotic Resistance in India: Drivers and Opportunities for Action. https://app.cochat.ai/papers/10.1371/journal.pmed.1001974
The paper
Laxminarayan, R., & Chaudhury, R. R. (2016). Antibiotic Resistance in India: Drivers and Opportunities for Action. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1001974

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.